Title : The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma.

Pub. Date : 2020

PMID : 32435618






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Among the novel anti-myeloma IT-based agents, anti-CD38 monoclonal antibodies (mAbs) are now becoming the new backbone of treatment for NTE patients, in association with lenalidomide and dexamethasone. Lenalidomide CD38 molecule Homo sapiens